Pertuzumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Pertuzumab and local guidelines before prescribing.

HER2 antibody

Mechanism

HER2 dimerisation inhibitor.

Uses

HER2-positive breast cancer (with trastuzumab).

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Diarrhoea, cardiotoxicity, neutropenia, infusion reactions.

Interactions

Few.

Contraindications and cautions

Left ventricular dysfunction

Monitoring

LVEF

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

LVEF monitoring.

More from the textbook: uses, cautions and other points
Where it is discussed in the book